0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Detection Methods Human Health Effects Nanoplastics Policy & Risk Sign in to save

Micro/nanoplastics in drugs that are stored in synthetic polymer bottles; an unseen danger to humans

Zenodo (CERN European Organization for Nuclear Research) 2022 Score: 35 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
N. Chandrasekaran

Summary

Researchers identified micro- and nanoplastic particles leaching from polyethylene terephthalate pharmaceutical storage bottles, isolating irregular transparent particles under 50 µm confirmed by Raman spectroscopy, raising concerns about the uncharacterized toxicological risk of plastic contamination in life-saving drugs stored in synthetic polymer containers.

Polymers

Most of the life-saving drugs are stored in synthetic polymer bottles. Our group has found out leaching of micro and nanoparticles into the drugs. What is the risk? The leaching of micro and nanoplastics and additives into the pharmaceutical formulation and its toxicological perspective on the human system is not yet studied in detail. Recently, our group has isolated micro and nanoplastics from pharmaceuticals especially by using an in-house developed extraction procedure. The isolated particles were irregular in shape with less than 50 µm in diameter. Most of the particles were transparent in nature and a few were colored particles. The Raman spectral analysis showed characteristics peaks at 638 cm-1, 852 cm-1, 1010 cm-1, 1121 cm-1, 1234 cm-1, 1348 cm-1, 1459 cm-1, 1608 cm-1, 2917 cm-1, 2943 cm-1, and 2969 cm-1 corresponding to the polyethylene terephthalate polymers. We suspect that these polymers could be leached from the storage containers made up of polyethylene terephthalate polymers. Leaching could have occurred through mechanical damage or chemical reaction with the pharmaceutical formulation. As medical plastics especially, single-use plastics are becoming a normalized requirement in the healthcare sector, their usage has been constantly increasing (especially due to the COVID pandemic). At present, the complete prohibition of plastic usage in healthcare settings is certainly a challenging process. More studies are required to study its characterization and how it interacts with the drug generic compound ? Also see: https://micro2022.sciencesconf.org/421197/document

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Micro-plastics as a source of contaminaion in pharmaceuticals

This review examined how microplastics contaminate pharmaceutical manufacturing environments and products, discussing the potential health risks of plastic particle exposure through medicines and the pathways by which microplastics enter pharmaceutical supply chains.

Article Tier 2

Nanoplastics in infusion system remains underexplored: Evidence from detected nanoplastics in hospital-sourced infusion products

Researchers analyzed hospital-sourced infusion products from three brands for nanoplastic contamination using surface-enhanced Raman spectroscopy combined with dark-field microscopy. The study detected a variety of nanoplastic particles in infusion products, suggesting that intravenous therapy may represent an underexplored pathway for direct nanoplastic exposure in clinical settings.

Article Tier 2

Microscopic Raman-based rapid detection of submicron/nano polypropylene plastics in tea and tea beverages

Using microscopic Raman spectroscopy, researchers detected and quantified submicron- and nanoscale polypropylene plastic particles leached into tea and tea beverages, expanding analytical focus beyond the commonly studied polystyrene model particles.

Article Tier 2

Impact of Microplastic Contaminants on Drug Stability and Safety

Researchers reviewed how microplastic contaminants may alter the stability, bioavailability, and safety of pharmaceutical products by adsorbing drug compounds and releasing them unpredictably. Survey data from pharmaceutical quality assurance professionals and literature synthesis identified specific mechanisms by which MPs could degrade drug formulations, flagging an underexplored drug safety concern.

Article Tier 2

Characterization of microplastics in water bottled in different packaging by Raman spectroscopy

Researchers detected and characterized microplastics in bottled water from different packaging types using Raman spectroscopy, confirming that plastic contamination occurs across various commercial water bottle materials.

Share this paper